OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
Víctor Albarrán-Artahona, Juan Carlos Laguna, Teresa Gorría, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2091-2091
Open Access | Times Cited: 12
Víctor Albarrán-Artahona, Juan Carlos Laguna, Teresa Gorría, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2091-2091
Open Access | Times Cited: 12
Showing 12 citing articles:
A Real-World Comparison of the Safety Profile for Immune Checkpoint Inhibitors in Oncology Patients
Abdulrahman Alwhaibi, Miteb Alenazi, Sultan Alghadeer, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 388-388
Open Access | Times Cited: 1
Abdulrahman Alwhaibi, Miteb Alenazi, Sultan Alghadeer, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 388-388
Open Access | Times Cited: 1
Endocrine side effects of immune checkpoint inhibitors
Zulma Cardona, Jeffrey A. Sosman, Sunandana Chandra, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 20
Zulma Cardona, Jeffrey A. Sosman, Sunandana Chandra, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 20
Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis—A Case Series
Nikhil Aggarwal, Diletta Bianchini, Rosemeen Parkar, et al.
Case Reports in Medicine (2024) Vol. 2024, pp. 1-5
Open Access | Times Cited: 7
Nikhil Aggarwal, Diletta Bianchini, Rosemeen Parkar, et al.
Case Reports in Medicine (2024) Vol. 2024, pp. 1-5
Open Access | Times Cited: 7
Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
A Javaid, Catherine Bennett, Aparna D. Rao, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 1, pp. 25-38
Open Access | Times Cited: 6
A Javaid, Catherine Bennett, Aparna D. Rao, et al.
Pharmaceutical Medicine (2024) Vol. 38, Iss. 1, pp. 25-38
Open Access | Times Cited: 6
Immune checkpoint inhibitors as a threat to reproductive function: A systematic review
Halahati Tuerxun, Yixin Zhao, Yawen Li, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 188, pp. 104064-104064
Open Access | Times Cited: 10
Halahati Tuerxun, Yixin Zhao, Yawen Li, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 188, pp. 104064-104064
Open Access | Times Cited: 10
The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis
Pengfei Zhao, Ting Zhao, Lihong Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Pengfei Zhao, Ting Zhao, Lihong Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Safety monitoring of drug-induced muscle injury and rhabdomyolysis: a biomarker-guided approach for clinical practice and drug trials
Patryk Ostrowski, Michał Bonczar, A Avram, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 10, pp. 1688-1699
Open Access | Times Cited: 5
Patryk Ostrowski, Michał Bonczar, A Avram, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 10, pp. 1688-1699
Open Access | Times Cited: 5
Immune Checkpoint Inhibitor Related Rheumatological Complications: Cooperation between Rheumatologists and Oncologists
Renata Pacholczak‐Madej, Joanna Kosałka-Węgiel, Piotr Kuszmiersz, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 4926-4926
Open Access | Times Cited: 3
Renata Pacholczak‐Madej, Joanna Kosałka-Węgiel, Piotr Kuszmiersz, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 4926-4926
Open Access | Times Cited: 3
Difficulties in differential diagnosis of hematological toxicity during therapy with immune checkpoint inhibitors
Р. В. Орлова, I. V. Avramenko
Clinical Case in Oncology (2024) Vol. 2, Iss. 1, pp. 23-29
Open Access
Р. В. Орлова, I. V. Avramenko
Clinical Case in Oncology (2024) Vol. 2, Iss. 1, pp. 23-29
Open Access
Редкие иммуноопосредованные нежелательные явления: клиническая характеристика, подходы к диагностике и лечению
Lyudmila Zhukova, О. С. Пасечнюк, Natalya I. Polshina, et al.
Malignant tumours (2024) Vol. 14, Iss. 3s1, pp. 53-62
Open Access
Lyudmila Zhukova, О. С. Пасечнюк, Natalya I. Polshina, et al.
Malignant tumours (2024) Vol. 14, Iss. 3s1, pp. 53-62
Open Access
A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management
Chiara Casadio, Linda Galvani, Andrea De Giglio, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 5, pp. 100083-100083
Open Access
Chiara Casadio, Linda Galvani, Andrea De Giglio, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 5, pp. 100083-100083
Open Access
Crossing the Blood-Brain Barrier: Advancing Immunotherapy for Pediatric Brain Tumors
Nima Taghizadeh Mortezaei, Adrina Habibzadeh, Zahra Rahimian, et al.
Interdisciplinary cancer research (2024)
Closed Access
Nima Taghizadeh Mortezaei, Adrina Habibzadeh, Zahra Rahimian, et al.
Interdisciplinary cancer research (2024)
Closed Access
